The Potential Economic and Public Health Impact of MDMA‐Assisted Group Therapy for PTSD in Ukraine
World Medical & Health Policy August 21, 2025 Elliot Marseille, Olga Chernoloz, О. И. Орлов 1 citation
Providing group MDMA-assisted therapy (MAT) with supplemental individual sessions for PTSD in Ukraine is likely cost-effective and could save lives. Modeling 1000 patients, treatment costs $1.1 million, averts 19.2 deaths, and gains 717 quality-adjusted life years (QALYs) over 3 years. From a healthcare payer perspective, MAT costs $1537 per QALY gained, considered cost-effective. From a societal perspective, it generates net savings of $2.6 million. Scaling to half of eligible patients over 10 years could save 48,000 lives and gain 1.5 million QALYs, with net societal savings of $5.6 billion. The findings support including MAT in Ukraine's mental health strategy.